These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Disease and treatment burden of psoriasis: examining the impact of biologics. Raval K; Lofland JH; Waters H; Piech CT J Drugs Dermatol; 2011 Feb; 10(2):189-96. PubMed ID: 21283925 [TBL] [Abstract][Full Text] [Related]
5. Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment. Kromer C; Schaarschmidt ML; Schmieder A; Herr R; Goerdt S; Peitsch WK PLoS One; 2015; 10(6):e0129120. PubMed ID: 26058083 [TBL] [Abstract][Full Text] [Related]
6. Patient preferences for psoriasis treatments: process characteristics can outweigh outcome attributes. Schaarschmidt ML; Schmieder A; Umar N; Terris D; Goebeler M; Goerdt S; Peitsch WK Arch Dermatol; 2011 Nov; 147(11):1285-94. PubMed ID: 22106115 [TBL] [Abstract][Full Text] [Related]
7. Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study. Christophers E; Segaert S; Milligan G; Molta CT; Boggs R J Dermatolog Treat; 2013 Jun; 24(3):193-8. PubMed ID: 22620684 [TBL] [Abstract][Full Text] [Related]
8. Satisfaction with treatment among patients with psoriasis: a web-based survey study. van Cranenburgh OD; de Korte J; Sprangers MA; de Rie MA; Smets EM Br J Dermatol; 2013 Aug; 169(2):398-405. PubMed ID: 23565643 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis. Bissonnette R; Kerdel F; Naldi L; Papp K; Galindo C; Langholff W; Tang KL; Szapary P; Fakharzadeh S; Srivastava B; Goyal K; Gottlieb AB J Drugs Dermatol; 2017 Oct; 16(10):1002-1013. PubMed ID: 29036254 [TBL] [Abstract][Full Text] [Related]
10. Elicitation and use of patients' preferences in the treatment of psoriasis: a systematic review. Umar N; Yamamoto S; Loerbroks A; Terris D Acta Derm Venereol; 2012 Jul; 92(4):341-6. PubMed ID: 22278662 [TBL] [Abstract][Full Text] [Related]
11. Patient preference for biologic treatments of psoriasis in Japan. Tada Y; Ishii K; Kimura J; Hanada K; Kawaguchi I J Dermatol; 2019 Jun; 46(6):466-477. PubMed ID: 30985030 [TBL] [Abstract][Full Text] [Related]
12. Comorbidities significantly impact patients' preferences for psoriasis treatments. Schmieder A; Schaarschmidt ML; Umar N; Terris DD; Goebeler M; Goerdt S; Peitsch WK J Am Acad Dermatol; 2012 Sep; 67(3):363-72. PubMed ID: 22015150 [TBL] [Abstract][Full Text] [Related]
13. Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions. Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E; Kemhus M Dermatol Online J; 2016 Jul; 22(7):. PubMed ID: 27617714 [TBL] [Abstract][Full Text] [Related]
14. Phototherapy, psoriasis, and the age of biologics. Richard EG; Hönigsmann H Photodermatol Photoimmunol Photomed; 2014 Feb; 30(1):3-7. PubMed ID: 24313462 [TBL] [Abstract][Full Text] [Related]
15. Psoriasis in Latin America. Chouela E; Amaya M; Londoño A; Romiti R; Valenzuela F; Duarte AA; Perez Alfonzo R; Borlenghi C Dermatol Online J; 2016 Sep; 22(9):. PubMed ID: 28329605 [TBL] [Abstract][Full Text] [Related]
16. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation. Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130 [TBL] [Abstract][Full Text] [Related]
17. Current challenges and emerging drug delivery strategies for the treatment of psoriasis. Hoffman MB; Hill D; Feldman SR Expert Opin Drug Deliv; 2016 Oct; 13(10):1461-73. PubMed ID: 27164301 [TBL] [Abstract][Full Text] [Related]
18. The importance of understanding patient and physician preferences for psoriasis treatment characteristics: a systematic review of discrete-choice experiments. Sain N; Willems D; Charokopou M; Hiligsmann M Curr Med Res Opin; 2020 Aug; 36(8):1257-1275. PubMed ID: 32468865 [No Abstract] [Full Text] [Related]
19. Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR). Strober B; Gooderham M; de Jong EMGJ; Kimball AB; Langley RG; Lakdawala N; Goyal K; Lawson F; Langholff W; Hopkins L; Fakharzadeh S; Srivastava B; Menter A J Am Acad Dermatol; 2018 Jan; 78(1):70-80. PubMed ID: 29102053 [TBL] [Abstract][Full Text] [Related]
20. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment. Gonzalez JM; Johnson FR; McAteer H; Posner J; Mughal F Br J Dermatol; 2017 Mar; 176(3):777-785. PubMed ID: 27292093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]